IL188064A0 - 2-(1h-indolylsulfanyl)-aryl amine derivatives - Google Patents

2-(1h-indolylsulfanyl)-aryl amine derivatives

Info

Publication number
IL188064A0
IL188064A0 IL188064A IL18806407A IL188064A0 IL 188064 A0 IL188064 A0 IL 188064A0 IL 188064 A IL188064 A IL 188064A IL 18806407 A IL18806407 A IL 18806407A IL 188064 A0 IL188064 A0 IL 188064A0
Authority
IL
Israel
Prior art keywords
indolylsulfanyl
amine derivatives
aryl amine
aryl
derivatives
Prior art date
Application number
IL188064A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of IL188064A0 publication Critical patent/IL188064A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL188064A 2005-06-17 2007-12-11 2-(1h-indolylsulfanyl)-aryl amine derivatives IL188064A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69200905P 2005-06-17 2005-06-17
PCT/IB2006/002785 WO2006134499A2 (en) 2005-06-17 2006-06-14 2-(1h-indolylsulfanyl)-aryl amine derivatives

Publications (1)

Publication Number Publication Date
IL188064A0 true IL188064A0 (en) 2008-03-20

Family

ID=37532681

Family Applications (1)

Application Number Title Priority Date Filing Date
IL188064A IL188064A0 (en) 2005-06-17 2007-12-11 2-(1h-indolylsulfanyl)-aryl amine derivatives

Country Status (15)

Country Link
EP (1) EP1893575B1 (enExample)
JP (1) JP5144507B2 (enExample)
KR (1) KR20080027462A (enExample)
CN (1) CN101238101A (enExample)
AR (1) AR054394A1 (enExample)
AU (1) AU2006257288A1 (enExample)
BR (1) BRPI0611748A2 (enExample)
CA (1) CA2611566C (enExample)
EA (1) EA200800070A1 (enExample)
ES (1) ES2616095T3 (enExample)
IL (1) IL188064A0 (enExample)
MX (1) MX2007014954A (enExample)
NO (1) NO20080265L (enExample)
WO (1) WO2006134499A2 (enExample)
ZA (1) ZA200710885B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2700199A1 (en) * 2007-09-24 2009-04-02 H. Lundbeck A/S Combination therapy related to serotonin dual action compounds
TW200938189A (en) * 2008-03-13 2009-09-16 Lundbeck & Co As H [2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders
ES2646834T3 (es) * 2010-08-20 2017-12-18 Amira Pharmaceuticals, Inc. Inhibidores de autotaxina y usos de los mismos
US9260416B2 (en) 2011-05-27 2016-02-16 Amira Pharmaceuticals, Inc. Heterocyclic autotaxin inhibitors and uses thereof
MX363680B (es) * 2013-03-15 2019-03-29 Chromocell Corp Compuestos moduladores del canal de sodio (nav1. 7) y sus usos para el tratamiento del dolor neuropatico, nociceptivo o inflamatorio.
JP2016530210A (ja) 2013-09-17 2016-09-29 ファーマケア,インク. ヘテロ環式ビニルオートタキシン阻害剤化合物
EP3046905A4 (en) 2013-09-17 2017-03-22 Pharmakea Inc. Vinyl autotaxin inhibitor compounds
US9850203B2 (en) 2013-09-26 2017-12-26 Pharmakea, Inc. Autotaxin inhibitor compounds
EP3878848A1 (en) 2013-11-22 2021-09-15 Sabre Therapeutics LLC Autotaxin inhibiting indole compounds
CN116059203A (zh) 2015-05-27 2023-05-05 赛博治疗有限责任公司 自分泌运动因子抑制剂及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117129A (en) * 1976-10-22 1978-09-26 Warner-Lambert Company Indolobenzoxazepines as cns depressants
ATE195125T1 (de) * 1995-11-06 2000-08-15 Dsm Nv Verfahren zur de-esterifikation
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
TW200400177A (en) * 2002-06-04 2004-01-01 Wyeth Corp 1-(Aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
AU2004303461B2 (en) * 2003-12-23 2011-04-28 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI
AR052308A1 (es) * 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto

Also Published As

Publication number Publication date
NO20080265L (no) 2008-01-15
BRPI0611748A2 (pt) 2016-11-22
ES2616095T3 (es) 2017-06-09
KR20080027462A (ko) 2008-03-27
CA2611566A1 (en) 2006-12-21
EA200800070A1 (ru) 2008-04-28
JP5144507B2 (ja) 2013-02-13
AU2006257288A1 (en) 2006-12-21
EP1893575A2 (en) 2008-03-05
AR054394A1 (es) 2007-06-20
JP2008546679A (ja) 2008-12-25
ZA200710885B (en) 2009-03-25
EP1893575B1 (en) 2017-01-11
WO2006134499A2 (en) 2006-12-21
MX2007014954A (es) 2008-02-15
CN101238101A (zh) 2008-08-06
CA2611566C (en) 2011-08-16
WO2006134499A3 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
AP2008004601A0 (en) Amine derivatives
IL189627A0 (en) Thiazole derivatives
IL194367A0 (en) Dihydropyrazolopyrimidinone derivatives
IL196543A0 (en) Pyridizinone derivatives
IL193641A0 (en) Spiroindolinone derivatives
EP1878727A4 (en) 2-AMINOQUINAZOLINE DERIVATIVES
IL195013A0 (en) Pyridopyrimidinone derivatives
IL196876A0 (en) 2-(heterocyclylbenzyl)pyridazinone derivatives
ZA200805411B (en) Aryl-isoxazolo-4-yl-oxadiazole derivatives
ZA200707358B (en) 1-benzylindole-2-carboxamide derivatives
IL195422A0 (en) 2-pyrazinecarboxamide derivatives
HUS2000022I1 (hu) Tiglien-3-on származékok
IL192401A0 (en) Indol-3-yl-carbonyl-spiro-piperidine derivatives
IL188064A0 (en) 2-(1h-indolylsulfanyl)-aryl amine derivatives
ZA200802088B (en) 4-Phenyl-6-substitued-pyrimidine-2-carbonitrile derivatives
ZA200802421B (en) 1-Acyldihydropyrazol derivatives
IL196364A0 (en) Aminoindazolylurea derivatives
IL195007A0 (en) Thiazole derivatives
ZA200804257B (en) Azaindole-2-carboxamide derivatives
IL193211A0 (en) Indazole-heteroaryl derivatives
IL192235A0 (en) Aryl-isoxazol-4-yl-imidazole derivatives
PL1954674T3 (pl) Nowe pochodne N-fenetylokarboksyamidu
GB0504019D0 (en) Amide derivatives
IL191138A0 (en) Pyrazoloisoquinoline derivatives
ZA200800920B (en) Amide derivatives